Are we ready for patient-reported outcomes in hepatocellular carcinoma?
2021-01-01 Personeni, Nicola; Rimassa, Lorenza
Hepatocellular Carcinoma : A Global Disease in Need of Individualized Treatment Strategies
2017-01-01 Personeni, N.; Rimassa, L.
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy
2025-01-01 Vitiello, Francesco; Vivaldi, Caterina; Rimini, Margherita; Prinzi, Federica Lo; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Salani, Francesca; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Gallio, Chiara; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Pircher, Chiara; Chon, Hong Jae; Braconi, Chiara; Qaisar, Aitzaz; Pastorino, Alessandro; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W.; Avallone, Antonio; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Couto, Nuno; Adeva, Jorge; Chan, Stephen Lam; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriguez, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Genovesi, Virginia; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Tesini, Giulia; Esposito, Luca; Boccancino, Alessandro; Himmelsbach, Vera; Landriscina, Matteo; Ahcene Djaballah, Selma; Bekaii-Saab, Tanios; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Fornaro, Lorenzo; Rimassa, Lorenza; Casadei-Gardini, Andrea
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib
2016-01-01 Rimassa, L.; Abbadessa, G.; Personeni, N.; Porta, C.; Borbath, I.; Daniele, B.; Salvagni, S.; Van Laethem, J.; Van Vlierberghe, H.; Trojan, J.; De Toni, E. N.; Weiss, A.; Miles, S.; Gasbarrini, A.; Lencioni, M.; Lamar, M. E.; Wang, Y.; Shuster, D.; Schwartz, B. E.; Santoro, A.
Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma
2021-01-01 Cammarota, Antonella; D'Alessio, Antonio; Pressiani, Tiziana; Rimassa, Lorenza; Personeni, Nicola
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
2020-01-01 Personeni, Nicola; Lleo, Ana; Pressiani, Tiziana; Colapietro, Francesca; Openshaw, Mark Robert; Stavraka, Chara; Pouptsis, Athanasios; Pinato, David James; Rimassa, Lorenza
Cabozantinib for the treatment of hepatocellular carcinoma
2019-01-01 Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population
2025-01-01 Rimini, Margherita; Fornaro, Lorenzo; Lo Prinzi, Federica; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Jae Chon, Hong; Braconi, Chiara; Qaisar, Aitzaz; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W; Avallone, Antonio; Corallo, Salvatore; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Malapelle, Umberto; Pepe, Francesco; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea
Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC)
2018-01-01 Rimassa, L; Assenat, E; Peck-Radosavljevic, M; Pracht, M; Zagonel, V; Mathurin, P; Rota-Caremoli, E; Porta, C; Daniele, B; Bolondi, L; Mazzaferro, V; Harris, W; Damjanov, N; Pastorelli, D; Reig, M; Knox, J; Negri, F; Trojan, J; López López, C; Personeni, N; Decaens, T; Dupuy, M; Sieghart, W; Abbadessa, G; Schwartz, B; Lamar, M; Goldberg, T; Shuster, D; Santoro, A; Bruix, J.
Reply to Y. Pointreau et al
2012-01-01 Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
2019-01-01 Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma
2013-01-01 Rimassa, L.; Pressiani, T.; Boni, C.; Carnaghi, C.; Rota Caremoli, E.; Fagiuoli, S.; Foa, P.; Salvagni, S.; Cortesi, E.; Tronconi, M. C.; Personeni, N.; Bozzarelli, S.; Banzi, M. C.; Fanello, S.; Romano Lutman, F.; Giordano, L.; Santoro, A.
Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer
2019-01-01 Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; De Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection
2011-01-01 Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A.; Pressiani, T.; Citterio, G.; Rossoni, G.; Donadoni, G.; Pozzi, F.; Rimassa, L.; Personeni, N.; Bozzarelli, S.; Rossoni, G.; Colombi, S.; De Braud, F. G.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C.
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients
2022-01-01 Crisafulli, Giovanni; Sartore-Bianchi, Andrea; Lazzari, Luca; Pietrantonio, Filippo; Amatu, Alessio; Macagno, Marco; Barault, Ludovic; Cassingena, Andrea; Bartolini, Alice; Luraghi, Paolo; Mauri, Gianluca; Battuello, Paolo; Personeni, Nicola; Zampino, Maria Giulia; Pessei, Valeria; Vitiello, Pietro Paolo; Tosi, Federica; Idotta, Laura; Morano, Federica; Valtorta, Emanuele; Bonoldi, Emanuela; Germano, Giovanni; Di Nicolantonio, Federica; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto
Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection
2011-01-01 Tronconi, M. C.; Sclafani, F.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Santoro, A.
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough?
2011-01-01 Personeni, N.; Torzilli, G.; Santoro, A.
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials
2022-01-01 Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Are we ready for patient-reported outcomes in hepatocellular carcinoma? | 1-gen-2021 | Personeni, Nicola; Rimassa, Lorenza | |
| Hepatocellular Carcinoma : A Global Disease in Need of Individualized Treatment Strategies | 1-gen-2017 | Personeni, N.; Rimassa, L. | |
| Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy | 1-gen-2025 | Vitiello, Francesco; Vivaldi, Caterina; Rimini, Margherita; Prinzi, Federica Lo; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Salani, Francesca; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Gallio, Chiara; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Pircher, Chiara; Chon, Hong Jae; Braconi, Chiara; Qaisar, Aitzaz; Pastorino, Alessandro; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W.; Avallone, Antonio; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Couto, Nuno; Adeva, Jorge; Chan, Stephen Lam; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriguez, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Genovesi, Virginia; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Tesini, Giulia; Esposito, Luca; Boccancino, Alessandro; Himmelsbach, Vera; Landriscina, Matteo; Ahcene Djaballah, Selma; Bekaii-Saab, Tanios; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Fornaro, Lorenzo; Rimassa, Lorenza; Casadei-Gardini, Andrea | |
| Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib | 1-gen-2016 | Rimassa, L.; Abbadessa, G.; Personeni, N.; Porta, C.; Borbath, I.; Daniele, B.; Salvagni, S.; Van Laethem, J.; Van Vlierberghe, H.; Trojan, J.; De Toni, E. N.; Weiss, A.; Miles, S.; Gasbarrini, A.; Lencioni, M.; Lamar, M. E.; Wang, Y.; Shuster, D.; Schwartz, B. E.; Santoro, A. | |
| Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma | 1-gen-2021 | Cammarota, Antonella; D'Alessio, Antonio; Pressiani, Tiziana; Rimassa, Lorenza; Personeni, Nicola | |
| Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options | 1-gen-2020 | Personeni, Nicola; Lleo, Ana; Pressiani, Tiziana; Colapietro, Francesca; Openshaw, Mark Robert; Stavraka, Chara; Pouptsis, Athanasios; Pinato, David James; Rimassa, Lorenza | |
| Cabozantinib for the treatment of hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A | |
| The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population | 1-gen-2025 | Rimini, Margherita; Fornaro, Lorenzo; Lo Prinzi, Federica; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Jae Chon, Hong; Braconi, Chiara; Qaisar, Aitzaz; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W; Avallone, Antonio; Corallo, Salvatore; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Malapelle, Umberto; Pepe, Francesco; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea | |
| Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC) | 1-gen-2018 | Rimassa, L; Assenat, E; Peck-Radosavljevic, M; Pracht, M; Zagonel, V; Mathurin, P; Rota-Caremoli, E; Porta, C; Daniele, B; Bolondi, L; Mazzaferro, V; Harris, W; Damjanov, N; Pastorelli, D; Reig, M; Knox, J; Negri, F; Trojan, J; López López, C; Personeni, N; Decaens, T; Dupuy, M; Sieghart, W; Abbadessa, G; Schwartz, B; Lamar, M; Goldberg, T; Shuster, D; Santoro, A; Bruix, J. | |
| Reply to Y. Pointreau et al | 1-gen-2012 | Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A | |
| Targeted agents for second-line treatment of advanced hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L | |
| Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C | |
| A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma | 1-gen-2013 | Rimassa, L.; Pressiani, T.; Boni, C.; Carnaghi, C.; Rota Caremoli, E.; Fagiuoli, S.; Foa, P.; Salvagni, S.; Cortesi, E.; Tronconi, M. C.; Personeni, N.; Bozzarelli, S.; Banzi, M. C.; Fanello, S.; Romano Lutman, F.; Giordano, L.; Santoro, A. | |
| Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer | 1-gen-2019 | Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; De Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S | |
| Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection | 1-gen-2011 | Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A | |
| Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A.; Pressiani, T.; Citterio, G.; Rossoni, G.; Donadoni, G.; Pozzi, F.; Rimassa, L.; Personeni, N.; Bozzarelli, S.; Rossoni, G.; Colombi, S.; De Braud, F. G.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C. | |
| Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients | 1-gen-2022 | Crisafulli, Giovanni; Sartore-Bianchi, Andrea; Lazzari, Luca; Pietrantonio, Filippo; Amatu, Alessio; Macagno, Marco; Barault, Ludovic; Cassingena, Andrea; Bartolini, Alice; Luraghi, Paolo; Mauri, Gianluca; Battuello, Paolo; Personeni, Nicola; Zampino, Maria Giulia; Pessei, Valeria; Vitiello, Pietro Paolo; Tosi, Federica; Idotta, Laura; Morano, Federica; Valtorta, Emanuele; Bonoldi, Emanuela; Germano, Giovanni; Di Nicolantonio, Federica; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto | |
| Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection | 1-gen-2011 | Tronconi, M. C.; Sclafani, F.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Santoro, A. | |
| Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? | 1-gen-2011 | Personeni, N.; Torzilli, G.; Santoro, A. | |
| Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials | 1-gen-2022 | Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista71908
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa64
- 2020 - 202616999
- 2010 - 201923026
- 2000 - 200918345
- 1990 - 19998891
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI972
- Elsevier Ltd761
- Elsevier B.V.651
- MDPI AG497
- Elsevier391
- John Wiley and Sons Inc327
- Springer321
- Multidisciplinary Digital Publish...309
- Springer Science and Business Med...299
- Elsevier Inc.264
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE384
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS282
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...196
- DOCTOR. OS183
- ACTA BIOMEDICA182
- NUTRIENTS180
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2917
- Female1597
- Male1493
- Middle Aged904
- Adult898
- Aged760
- Animals652
- Italy592
- Medicine (all)464
- COVID-19459
Lingua
- eng43532
- ita9129
- fre232
- spa124
- ger99
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext58598
- reserved8052
- open3768
- partially open822
- restricted667
- embargoed2
- mixed1